Company Filing History:
Years Active: 2006-2009
Title: Volker Gawantka: Innovator in Fibrinogen Purification
Introduction
Volker Gawantka is a notable inventor based in Lahntal, Germany. He has made significant contributions to the field of biochemistry, particularly in the purification and formulation of fibrinogen. With a total of 2 patents, Gawantka's work has implications for pharmaceutical preparations and medical applications.
Latest Patents
Gawantka's latest patents include a process for purifying fibrinogen. This invention involves one or more process steps that deplete contaminating proteins through negative chromatography and/or negative adsorption using cation exchangers, hydrophobic gels, and/or dye gels. The resulting fibrinogen is characterized by improved stability, making it suitable for pharmaceutical preparations. Another significant patent is for a storage-stable, liquid fibrinogen formulation that includes divalent metal ions. This formulation may also contain other conventional ingredients, particularly a complexing agent, enhancing its usability in medical applications.
Career Highlights
Throughout his career, Volker Gawantka has worked with prominent companies in the biopharmaceutical industry. He has been associated with ZLB Behring GmbH and CSL Behring GmbH, where he has contributed to advancements in fibrinogen research and development.
Collaborations
Gawantka has collaborated with notable colleagues, including Hubert Metzner and Uwe Liebing. These collaborations have further enriched his research and innovations in the field.
Conclusion
Volker Gawantka's contributions to fibrinogen purification and formulation highlight his role as an innovator in biochemistry. His patents reflect a commitment to improving medical applications and pharmaceutical preparations.